5 Key Takeaways

• 1

  Lower potassium supplementation thresholds may effectively prevent atrial fibrillation after cardiac surgery.

• 2

  The TIGHT K clinical trial involved 1,690 patients undergoing isolated coronary artery bypass grafting.

• 3

  The primary endpoint showed 26.2% AFACS in the tight control group versus 27.8% in the relaxed control group.

• 4

  The relaxed potassium supplementation strategy resulted in a mean per-patient cost savings of $111.89.

• 5

  No significant differences were found in secondary outcomes between the two potassium supplementation strategies.